Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by High Susanna Gatti. Officer active across 1 company, notably Dyne Therapeutics, Inc.. In total, 24 filings have been published. Split: 0 buy · 14 sells. Total volume traded: €1.3m. History available since 23 September 2021. The latest transaction was filed on 18 September 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to High Susanna Gatti
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
4,340 shares@ US$34.415.9% of flowCommon StockSEC:0000950170-24-108154:0
2,548 shares@ US$31.893.2% of flowCommon StockSEC:0000950170-24-105512:0
2,582 shares@ US$45.014.6% of flowCommon StockSEC:0000950170-24-099124:0
29,787 shares@ US$5.546.8% of flowCommon StockSEC:0000950170-24-081748:0
29,787 shares@ US$5.546.8% of flowCommon StockSEC:0000950170-24-077029:0
40,000 shares@ US$5.549.0% of flowCommon StockSEC:0000950170-24-073289:0
80,000 shares@ US$5.5418.0% of flowCommon StockSEC:0000950170-24-072153:0
2,249 shares@ US$28.202.6% of flowCommon StockSEC:0000950170-24-062078:0
26,908 shares@ US$26.6628.7% of flowCommon StockSEC:0000950170-24-030485:0
1,591 shares@ US$25.851.7% of flowCommon StockSEC:0000950170-24-029614:0
1,616 shares@ US$10.720.7% of flowCommon StockSEC:0001209191-23-058329:0
94,893 shares0Common StockSEC:0001209191-23-055526:0
9,939 shares@ US$7.403.0% of flowCommon StockSEC:0001209191-23-054194:0
2,672 shares@ US$9.418.5% of flowCommon StockSEC:0001209191-23-050172:0
1,635 shares@ US$10.410.7% of flowCommon StockSEC:0001209191-23-049359:0
1,625 shares@ US$12.430.8% of flowCommon StockSEC:0001209191-23-037166:0
1,559 shares@ US$13.330.8% of flowCommon StockSEC:0001209191-23-018980:0
44,000 shares0Common StockSEC:0001209191-22-060970:0
2,629 shares@ US$13.701.6% of flowCommon StockSEC:0001209191-22-050888:0
786 shares@ US$14.050.5% of flowCommon StockSEC:0001209191-22-050120:0
802 shares@ US$4.950.2% of flowCommon StockSEC:0001209191-22-037146:0
765 shares@ US$8.730.3% of flowCommon StockSEC:0001209191-22-018535:0
40,315 shares0Common StockSEC:0001209191-21-069423:0
2,451 shares@ US$17.221.7% of flowCommon StockSEC:0001209191-21-057527:0
About High Susanna Gatti
HIGH SUSANNA GATTI is a declarant linked to Dyne Therapeutics, Inc. (XNAS), where she is Chief Operating Officer. The record shows 24 filings, and across the 24 sampled filings between 2021-09-24 and 2024-09-19, sales total 1320192 EUR and the modal transaction nature is sale.